Genu Recurvatum Market Size, Share And Growth Analysis For 2024-2033
The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033
LONDON, GREATER LONDON, UK, July 2, 2024 /EINPresswire.com/ -- The genu recurvatum market3 has experienced robust growth recently, expanding from $7.12 billion in 2023 to $7.57 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. This growth is attributed to the increasing prevalence of orthopedic conditions, an aging population, trauma, accidents, limited awareness, and early diagnosis. The market is projected to grow to $9.71 billion by 2028, at a CAGR of 6.4%, driven by rising awareness and education, advancements in treatment options, sports injury prevention and management, and rehabilitation programs.
Increasing Prevalence of Orthopedic Disorders Drives Market Growth
The increasing prevalence of orthopedic disorders is expected to propel the growth of the genu recurvatum market. Orthopedic disorders affect the musculoskeletal system, causing knee pain and leading to conditions like knee osteoarthritis. The growing number of orthopedic conditions will demand treatment, supporting market growth. For instance, in February 2022, the Office of Disease Prevention and Health Promotion projected that by 2040, 78.4 million adults in the U.S. will have arthritis. Similarly, in 2021, Versus Arthritis reported that over 20 million people in the UK had musculoskeletal conditions. These increasing cases of orthopedic disorders are driving the growth of the genu recurvatum market.
Explore comprehensive insights into the global genu recurvatum market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=12425&type=smp
Key Players and Market Trends
Major companies operating in the genu recurvatum market include Medtronic PLC, Johnson & Johnson MedTech, Stryker Corporation, DePuy Synthes Inc., Zimmer Inc., Smith & Nephew PLC, Arthrex, NuVasive Inc., DJO Global Inc., Globus Medical Inc., Össur hf, AliMed Inc., Thuasne Ltd., Orthofix Inc., Prim SA, OrthoPro Inc., Performance Health, Trulife Group Limited, Breg Inc., Allard USA, Capstone Orthopedic Inc., Twin Cities Orthopedics, ReWalk Robotics, BraceAbility, and KevinRoot Medical.
Companies in the genu recurvatum market are focusing on developing innovative solutions like microprocessor prosthetic knees. For example, in September 2022, Össur launched the ‘POWER KNEE,’ the world’s first actively powered microprocessor prosthetic knee. This revolutionary bionic technology detects human movement patterns, learns, and dynamically adjusts to the wearer's speed and cadence in real-time.
Segments
• Type: External Rotatory Deformity (ERD), Internal Rotatory Deformity (IRD), Non-Rotatory Deformity (NRD)
• Diagnosis: Magnetic Resonance Imaging (MRI), X-Rays, Other Diagnosis
• Treatment: Physical Therapy, Orthoses, Bracing, Surgery
• End-Users: Hospital, Clinics, Other End-Users
Geographical Insights: North America Leading, Asia-Pacific Growing Fastest
North America was the largest region in the genu recurvatum market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genu recurvatum market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Explore the report store to make a direct purchase of the report https://www.thebusinessresearchcompany.com/report/genu-recurvatum-global-market-report
Genu Recurvatum Global Market Report 20242 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Genu Recurvatum Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on genu recurvatum market size, genu recurvatum market drivers and trends, genu recurvatum market major players, competitors' revenues, market positioning, and market growth across geographies. The genu recurvatum market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Knee Implants Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/knee-implants-global-market-report
Arthritis Monoclonal Antibodies Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report
Psoriatic Arthritis Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/psoriatic-arthritis-treatments-global-market-report
About The Business Research Company1
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
1 https://www.thebusinessresearchcompany.com/
2 https://www.thebusinessresearchcompany.com/report/genu-recurvatum-global-market-report
3 https://www.thebusinessresearchcompany.com/report/genu-recurvatum-global-market-report